ALS patients could gain greater control of their lives through brain, voice and eye commands

Read about Accenture and Royal Philips announcing Proof of Concept App to show how the use of wearable devices in the Medical Technology Industry could improve the quality of life for patients.

Accenture and Royal Philips have collaborated to create a proof-of-concept app that demonstrates how wearable technology can be used to improve the quality of life for individuals with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Through this application, a wearable display and Emotive Insight Brainwave technology are connected to a tablet, allowing the patient to use eye and voice commands to control various medical technology products. This application demonstrates how the use of wearable devices and other medical technology could affect the lives of more than 400,000 patients a year who suffer from diseases that diminish voluntary muscle functionality.

“This proof of concept exemplifies how people, devices, data and technology could be brought together quickly to connect beyond the hospital walls in a way that can potentially help improve the quality of life for patients, wherever they are in their journey,” said Jeroen Tas, CEO, Healthcare Informatics Solutions and Services for Philips. “Philips will continue to collaborate with innovative technology companies such as Accenture to explore new wearable and sensor solutions that change peoples’ lives and create a healthier future.”